Evidence map›Paper›PMID 42909056›Full record

ArticleFrontiers in veterinary science2026

Case Report: Allogeneic adipose-derived mesenchymal stem cells for severe chronic kidney disease in a dog.

Yu Yu, Xuemin Lv, Xinyuan Zhou, Yuxin Ma, Hao Li, Weiwei Wang, Yizhe Song

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yu YuCollege of Life Sciences, Yantai University, Yantai, Shandong, China.
Xuemin LvCollege of Life Sciences, Yantai University, Yantai, Shandong, China.
Xinyuan ZhouCollege of Life Sciences, Yantai University, Yantai, Shandong, China.
Yuxin MaCollege of Life Sciences, Yantai University, Yantai, Shandong, China.
Hao LiOUR PET Hospital, Shanghai, China.
Weiwei WangCollege of Life Sciences, Yantai University, Yantai, Shandong, China.
Yizhe SongCollege of Life Sciences, Yantai University, Yantai, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report explored the clinical improvement and short-term tolerability of allogeneic adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment of severe chronic kidney disease (CKD) in dogs. A 9-year-old female Pomeranian was diagnosed with chronic kidney disease (CKD) caused by acute kidney injury and, after conventional treatment failed, received intravenous infusion of AD-MSCs from healthy donor dogs. The AD-MSCs were aseptically collected, isolated, cultured, characterized, and subjected to microbiological safety testing, and were then administered intravenously at a dose of 3 × 10

Indexed as

adipose-derived mesenchymal stem cellsallogeneic stem cell therapycanine chronic kidney diseaserenal fibrosisrenal regenerative medicine

Identifiers

PMID42909056
PMCPMC13683740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.